ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug

Journal: International Journal of Science and Research (IJSR) (Vol.9, No. 6)

Publication Date:

Authors : ;

Page : 69-73

Keywords : COVID-19; SARS-CoV-2; Mefenamic acid; serine protease inhibitor; NLRP3 inflammasome;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

COVID-19 (coronavirus disease 2019) is a Pandemic of concern, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As of now, there is no known effective pharmaceutical or other medicine available for cure or prevention of COVID-19. In this review, based on the current understanding of the disease and the structure of novel Coronavirus SARS-CoV-2, SARS-CoV and other human viruses, I have identified Mefenamic Acid, an anti-inflammatory medicine, of having some role as an anti-viral medicine also. It can be used along with different anti-viral drugs being tried for the treatment of Covid 19. Since it is also an anti-pyretic, its main role may be of bringing down the fever but its action as an anti-viral, as a supportive medicine can very useful. Clincal trials with this concept in mind can be started immediately at the Centre dedicated for treatment of Covid 19.

Last modified: 2021-06-28 17:08:00